Based on early human studies and animal research, GLP-1 agonists may affect: Reward-related eating behaviours by potentially modulating dopamine signalling in brain reward circuits Food cravings and hedonic eating (eating for pleasure rather than hunger) Impulsivity around food , possibly reducing the compulsive aspects of eating Satiety signalling , enhancing the feeling of fullness after meals Some patients using GLP-1 medications for diabetes or weight management report not just reduced appetite but also diminished preoccupation with food, fewer intrusive thoughts about eating, and reduced cravings for specific foods, particularly those high in fat and sugar
Medically supervised programs consider individual conditions like diabetes, PCOS, or thyroid issues and tailor recommendations accordingly
Gentle exercise such as walking, swimming, or yoga promotes circulation, enhances mood, and supports metabolic health
Heres how to avoid being a victim Federal Trade Commission crackdown on company selling GLP-1 is a reminder of the dangers consumers face when purchasing trending treatments online Bookmark CommentsGo to comments If it sounds too good to be true, then you probably shouldnt buy it
